Advaita Bioinformatics displaces major competitor in Australia and New Zealand

235
0
SHARE

United States, Michigan, Ann Arbor – 04-23-2019 (PRDistribution.com) — Advaita announces new distribution partnership with Millennium Science

Advaita Bioinformatics (www.advaitabio.com), provider of the industry-leading gene expression and genomic variation analysis platform, announces a new partnership with Millennium Science for distribution of Advaita’s software to research institutions and pharma companies across Australia and New Zealand. The partnership is effective immediately and Millennium Science is replacing Qiagen’s Ingenuity products with iPathwayGuide and iVariantGuide products for all pathway and variant analysis.

According to Millennium Science’s Business Development Manager, James Miller: We reviewed the currently available products for pathway and variant analysis and we have declared iPathwayGuide and iVariantGuide the best.  We are delighted to offer our customers superior and simpler-to-use products for their very important and mission-critical work.  We felt that our previous Ingenuity [Pathway and Variant Analysis] offering was very expensive, with additional costs of add-on modules and the platform was becoming out of reach for many labs. iPathwayGuide and iVariantGuide provide all the key insights that Ingenuity was providing – and much more – with a more intuitive interface and at a lower cost, with a simple and practical license structure.

Miller goes on to say: “Methods for pathway and variant analysis are changing and the tools are getting better. When we saw how Advaita’s iPathwayGuide Impact Analysis worked and what it was capable of, and how easy it was to get more meaning from variant data with iVariantGuide, we knew it was time to show our customers an alternative approach.  Tools for extracting biological meaning out of data are in demand. Trying to achieve this without high-quality visual tools for pathway analysis and variant filtering takes too much time and risks missing important connections. But the tools need to be affordable, they need to be easy to use, they need to not miss things and they shouldn’t create more confusion. That’s where Advaita comes in with incredible capabilities and unparalleled value.”

“This partnership is a big step forward for Advaita Bioinformatics,” said Sorin Draghici, Advaita’s CEO. “We have worked very hard to ensure that we offer our customers superior capabilities, and the fact that a prestigious provider of life sciences technologies such as Millennium Science has chosen to replace Qiagen’s tools with ours throughout Australia and New Zealand, is very rewarding for us.”

The deal is a three-year commitment. Millennium Science is converting its current clients to Advaita products and selling new cloud-based subscriptions to new customers immediately.

About the Platform:

Advaita software tools help principal investigators, core facilities, and bioinformatics teams analyze very large sets of gene expression data (e.g. RNA-Seq or microarray) and variant data (e.g. DNA-Seq) to find biomarkers, identify impacted pathways, and pinpoint putative mechanisms. Prior to adoption of Advaita’s cloud-based systems-biology platform, this process was slow, unreliable, expensive, and often required multiple disjointed tools leading to irrelevant or incorrect results. Advaita solutions modernize this process with tools designed to provide superior results at a lower price, make collaboration across labs simple, model the effects of multiple biological mechanisms (e.g. gene expression, genomic variation, pathways, drugs, miRNAs, upstream regulators, diseases, Gene Ontology annotation, and gene-gene interactions), AND generate beautiful publication-ready graphics. In addition, iBioGuide provides a wealth of knowledge on all of these mechanisms, allowing researchers to investigate their hypothesis of interest in great detail.

About Advaita Bioinformatics:

Advaita is the leader in the interpretation of high-throughput biomedical data including variant interpretation, pathway analysis, disease subtype discovery and integration across multiple data types. Currently, 9 of the top 10 pharma companies rely on Advaita’s state-of-the-art algorithms to solve complex problems. Advaita provides a suite of advanced analysis software to more that 13,000 registered users worldwide: iPathwayGuide, for functional interpretation of genes and proteins; iVariantGuide, for genetic variant analysis; and iBioGuide, a search engine revealing connections between genes, pathways, SNPs, drugs, and more.

About Millennium Science

Millennium Science is a privately-held, specialist distribution company established in 1999 specifically to source, supply and support high technology solutions to the life science market in Australia and New Zealand. Celebrating 20 years of operation in 2019, the company has grown to be the leading distributor of technology for the biotechnology research market.

Millennium Science has a core competency in the delivery of high technology products, including hardware, software and consumables. We focus heavily on pre- and post-sales technical support and employ scientifically qualified technical sales representatives, backed up by Ph.D. qualified application scientists, a team of highly trained and experienced service engineers, marketing, customer service, administrative and office support staff.

Millennium Science partners with carefully selected manufacturers who are market leaders in their chosen fields and are equally customer focused.

Media Contacts:

Company Name: Advaita Bioinformatics
Full Name: Ted Dacko
Phone: 734-604-5417
Email Address: Send Email
Website: www.advaitabio.com

For the original news story, please visit https://prdistribution.com/news/advaita-bioinformatics-displaces-major-competitor-in-australia-and-new-zealand.html.

Powered by WPeMatico